Zoll takes a battering over profit warning
This article was originally published in Clinica
Executive Summary
Zoll Medical's share price plunged by over 50% to around $16 after the company warned that its second-quarter earnings-per-share will be "substantially below" the consensus of $0.30 - at $0.07-0.11. Revenues will be flat at some $25-26 million, as the North American order rate was significantly lower than anticipated, the company warned.